STAT: stem cell advocates seek RFK Jr. opening after peptide policy shift
Backers of looser stem cell access are modeling their push on the regulatory latitude peptides have gained under the current health leadership.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 5 15:58 ETSource: STAT
The wire
- 01STAT reports that advocates for expanded stem cell access see the recent political treatment of peptides as a template for what RFK Jr.'s health department might do for cell therapies.
- 02The framing matters for peptide clinics and compounders, whose regulatory status is now being cited as precedent in adjacent fights over unapproved therapies.
- 03Article text beyond the headline was not detailed here; no formal FDA or agency action on either category is described.
From the source
Read at statnews.comAre stem cells the next peptides? These advocates think RFK Jr. could make it happen
